$4.66
4.37% today
Nasdaq, Oct 13, 04:51 pm CET
ISIN
US1409351079
Symbol
CV

CapsoVision Stock price

$4.46
+0.83 22.87% 1M
-0.54 10.80% 6M
-0.54 10.80% YTD
-0.54 10.80% 1Y
-0.54 10.80% 3Y
-0.54 10.80% 5Y
-0.54 10.80% 10Y
-0.54 10.80% 20Y
Nasdaq, Closing price Fri, Oct 10 2025
-0.19 3.98%
ISIN
US1409351079
Symbol
CV

Key metrics

Basic
Market capitalization
$208.6m
Enterprise Value
$208.5m
Net debt
positive
Cash
$1.1m
Shares outstanding
46.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
11.7 | 14.3
EV/Sales
11.7 | 14.3
EV/FCF
negative
P/B
45.0
Financial Health
Equity Ratio
84.0%
Return on Equity
-141.0%
ROCE
-561.9%
ROIC
-434.2%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$17.9m | $14.6m
EBITDA
$-29.5m | -
EBIT
$-30.0m | $-22.4m
Net Income
$-29.9m | $-31.7m
Free Cash Flow
$-25.8m
Growth (TTM | estimate)
Revenue
- | 23.8%
EBITDA
- | -
EBIT
- | -12.4%
Net Income
- | -59.5%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
54.2%
EBITDA
-165.0% | -
EBIT
-167.8%
Net
-167.5% | -218.0%
Free Cash Flow
-144.5%
More
EPS
$-0.7
FCF per Share
$-0.6
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is CapsoVision a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,002 stocks worldwide.

CapsoVision Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a CapsoVision forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a CapsoVision forecast:

Buy
90%
Hold
10%

Financial data from CapsoVision

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
18 18
-
100%
- Direct Costs 8.17 8.17
-
46%
9.68 9.68
-
54%
- Selling and Administrative Expenses 18 18
-
101%
- Research and Development Expense 22 22
-
121%
-29 -29
-
-165%
- Depreciation and Amortization 0.50 0.50
-
3%
EBIT (Operating Income) EBIT -30 -30
-
-168%
Net Profit -30 -30
-
-168%

In millions USD.

Don't miss a Thing! We will send you all news about CapsoVision directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CapsoVision Stock News

Neutral
GlobeNewsWire
2 months ago
- Conference Call Scheduled for Thursday, August 14, 2025 at 4:30 pm ET - SARATOGA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies that are deployed in its capsule endoscopy solutions, today announced that the company will release second quarter...

Company Profile

CapsoVision Inc is a US-based company operating in industry. The company is headquartered in Saratoga California, California. The company went IPO on 2025-07-02. CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.

Head office United States
Website www.capsovision.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today